Header Logo

Connection

MICHAEL BRAUN to Anthracyclines

Back to Details
This is a "connection" page, showing publications MICHAEL BRAUN has written about Anthracyclines.
MICHAEL BRAUN
Connection Strength
0.055
Anthracyclines
  1. Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial. Mol Cancer. 2025 Mar 26; 24(1):96.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.